Public investment in cancer research has earned a rate of return equivalent to 40% a year, it is claimed today.
A new report says the most effective investments have been in breast cancer treatment, in cervical cancer screening and in campaigns to cut smoking rates.
Just a quarter of the benefits come from improvements in health while other benefits come from "spill over" effects to the economy, according to the study.
The research was commissioned by the Academy of Medical Sciences, Cancer Research UK, the Department of Health and the Wellcome Trust.
Researchers from Brunel University, Kings College London and RAND Europe, studied the benefits of cancer research from a period between 1970 and 2009.
The findings were welcomed by the organisations which commissioned the research.
The president of the Academy of Medical Sciences Professor Sir John Tooke said: "This study helps make the case for sustained investment in medical research.
"It demonstrates that past support for cancer research not only helps create a healthier society but aids the health of the economy now and into the future."
Cancer Research UK chief executive Dr Harpal Kumar said: “This study highlights the significant returns that have been realised as a result of the huge generosity of the British public, who in the last 40 years have contributed an astounding £15 billion to cancer research through their taxes and charitable donations.
"What this report shows is that the benefits of research don’t just stop with cancer patients. They extend to everyone living here in the UK.”
Glover M. et al. Estimating the returns to UK publicly funded cancer-related research in terms of the net value of improved health outcomes, BMC Medicine 16 June 2014; doi: 10.1186/1741-7015-12-99 [abstract]

Leave a Reply